Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment

Healthpoint

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: Xenaderm; Drug: Placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT00644917

011 101 09 001

Details and patient eligibility

About

The product is being tested to see if exposure to light causes toxic reactions on the skin.

Enrollment: 38 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy subjects

Exclusion criteria

• Under 18 years of age

Trial design

38 participants in 3 patient groups, including a placebo group

A

Experimental group

Description:

Drug

Treatment:

Drug: Xenaderm

B

Placebo Comparator group

Description:

Placebo comparator

Treatment:

Drug: Placebo

C

No Intervention group

Description:

Subjects serve as own controls.